← Back to Search

light-scattering spectroscopy for Breast Cancer

N/A
Waitlist Available
Research Sponsored by Vanderbilt University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Male or female
Menopausal status not specified
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights

Study Summary

This trial is using optical spectroscopy to see how well it works in evaluating tumor margins in patients who have undergone surgery for breast cancer.

Eligible Conditions
  • Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
Both males and females can participate.
Select...
It is not known if you have gone through menopause or not.
Select...
Please refer to the section on the type of illness or disease that is being studied.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Development of a non-invasive detection tool that evaluates breast tumor margins in real-time to guide tumor resection during partial mastectomy procedures
Evaluated optical spectroscopy in differentiating breast tumor or tumor margins from normal breast tissue

Trial Design

1Treatment groups
Experimental Treatment
Group I: Optical spectroscopy on tumor marginsExperimental Treatment4 Interventions
Optical spectroscopy is performed on breast tumor margins obtained from patients undergoing surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
breast biopsy
2006
N/A
~110
light-scattering spectroscopy
2006
N/A
~110
therapeutic conventional surgery
2003
Completed Phase 3
~12270
histopathologic examination
2003
Completed Phase 2
~170

Find a Location

Who is running the clinical trial?

Vanderbilt UniversityLead Sponsor
703 Previous Clinical Trials
6,143,229 Total Patients Enrolled
11 Trials studying Breast Cancer
1,430 Patients Enrolled for Breast Cancer
National Cancer Institute (NCI)NIH
13,638 Previous Clinical Trials
40,929,717 Total Patients Enrolled
939 Trials studying Breast Cancer
1,543,258 Patients Enrolled for Breast Cancer
Anita Mahadevan-Jansen, MDStudy Chair - Vanderbilt-Ingram Cancer Center
Vanderbilt University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has this research been embraced by participants?

"Valid. According to clinicaltrials.gov, the trial commenced on August 1st 2006 and is actively recruiting for 180 participants from three distinct healthcare facilities as of December 6th 2021."

Answered by AI

Are participants being recruited for this experiment currently?

"Affirmative. Per the clinicaltrials.gov database, this research initiative is open to new participants and has been since August 1st 2006 (last updated December 6th 2021). A total of 180 patients are being sought at 3 medical centres."

Answered by AI

Is this research open to individuals in the geriatric age range?

"Patients aged 18 to 99 may enroll in this trial. There are 74 trials for minors and 2508 for seniors."

Answered by AI

Who is eligible to partake in this research experiment?

"Eligibility criteria for this study includes a diagnosis of breast cancer and an age between 18-99 years old. 180 total participants will be enrolled in the trial."

Answered by AI
~5 spots leftby Apr 2025